title: [Atopic dermatitis: a modern view of pediatricians and pediatric allergologist].
abstract: The article presents the views of pediatric allergologist on the problem of atopic dermatitis/ atopic eczema in children. Atopic dermatitis (AD) is considered from a modern viewpoint of allergic 'march', which is characteristic (typical) for children with atopy. These data indicate to systemic nature of atopic 'march', the first step of which is atopic eczema. Further evolution of atopic dermatitis leads to a transformation of it in other atopic diseases--allergic rhinitis and bronchial asthma; this fact indicates that immunopathological disorders are united in these diseases and it conditions the possibility of prevention. It has taken into consideration the systemic nature of atopic diseases, combined therapy is great important and has to include not only basic local therapy, in particular topical corticosteroids (mometasone furoate--Elokom) during the exacerbation, and the systematic elimination of trigger factors, diet, the removal of the digestive system dysfunctions and the imbalance of vitamins. A long-time systemic basic therapy by H1-antihistamines of second generation, such as desloratadine (Aerius) takes a special place in the treatment of atopic dermatitis.
authors.forename: O M
authors.initials: OM
authors.lastname: Okhotnikova
mesh_terms: D000287:Administration, Topical; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use; D000485:Allergens / Q000276:immunology*; D001249:Asthma / Q000150:complications / Q000178:diet therapy / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology*; D001361:Avitaminosis / Q000517:prevention & control; D002648:Child; D003876:Dermatitis, Atopic / Q000150:complications / Q000178:diet therapy / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology*; D004032:Diet / Q000379:methods*; D039563:Histamine H1 Antagonists, Non-Sedating / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology; D007155:Immunologic Factors / Q000008:administration & dosage / Q000627:therapeutic use; D017336:Loratadine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D000068656:Mometasone Furoate; D010372:Pediatrics; D011244:Pregnadienediols / Q000008:administration & dosage / Q000627:therapeutic use; D012221:Rhinitis, Allergic, Perennial / Q000150:complications / Q000178:diet therapy / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology*; D014815:Vitamins / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D000305:Adrenal Cortex Hormones; D000485:Allergens; D039563:Histamine H1 Antagonists, Non-Sedating; D007155:Immunologic Factors; D011244:Pregnadienediols; D014815:Vitamins; D000068656:Mometasone Furoate; D007073:Immunoglobulin E; D017336:Loratadine; C121345:desloratadine